ArticleOncogene2022
A high-throughput drug screen reveals means to differentiate triple-negative breast cancer.
Milica Vulin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleOncogene2022
Milica Vulin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.